Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanyang Nan

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
International Journal of Pharmaceutics|January 29, 2025
Rubicon siRNA-encapsulated liver-targeting nanoliposome is a promising therapeutic for non-alcoholic fatty liver diseaseYuting Zhang, Hanqi Wang, Caili Xu, et al.
Cell Death & Disease|November 14, 2023
Inhibition of Hedgehog signaling ameliorates foam cell formation by promoting autophagy in early atherosclerosisYuting Zhang, Weijuan Xin, Xiaozhi Hu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 17, 2024
Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancerCaili Xu, Xiting Huang, Qinchao Hu, et al.
Biomedicines|May 25, 2024
A Novel Bifunctional Fusion Protein (Anti-IL-17A-sST2) Protects against Acute Liver Failure, Modulating the TLR4/MyD88 Pathway and NLRP3 Inflammasome ActivationYu Bai, Rongrui Zhou, Xinlei Xie, et al.
Applied Microbiology and Biotechnology|May 14, 2018
Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastomaXuyao Zhang, Shaofei Wang, Yanyang Nan, et al.
Frontiers in Immunology|August 21, 2018
Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin EYichen Wang, Xuyao Zhang, Jiajun Fan, et al.
Cell Death & Disease|April 25, 2024
A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAEYichen Wang, Yanyang Nan, Chunguang Ma, et al.
International Journal of Biological Macromolecules|November 5, 2025
ANGPTL3 nanobody-FGF21 fusion protein ameliorates metabolic dysfunction-associated fatty liver disease via regulation of lipid and glucose metabolism and attenuation of oxidative stressYuanzhen Zhang, Xiaozhi Hu, Zhonglian Cao, et al.
Carcinogenesis|March 15, 2018
Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastomaXuyao Zhang, Wei Chen, Jiajun Fan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 18, 2025
Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8<sup>+</sup> T cell and evading IL-18BP in preclinical modelsYanyang Nan, Min Zhu, Qian Wang, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Pharmaceutics|January 29, 2025
Rubicon siRNA-encapsulated liver-targeting nanoliposome is a promising therapeutic for non-alcoholic fatty liver diseaseYuting Zhang, Hanqi Wang, Caili Xu, et al.
Cell Death & Disease|November 14, 2023
Inhibition of Hedgehog signaling ameliorates foam cell formation by promoting autophagy in early atherosclerosisYuting Zhang, Weijuan Xin, Xiaozhi Hu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 17, 2024
Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancerCaili Xu, Xiting Huang, Qinchao Hu, et al.
Biomedicines|May 25, 2024
A Novel Bifunctional Fusion Protein (Anti-IL-17A-sST2) Protects against Acute Liver Failure, Modulating the TLR4/MyD88 Pathway and NLRP3 Inflammasome ActivationYu Bai, Rongrui Zhou, Xinlei Xie, et al.
Applied Microbiology and Biotechnology|May 14, 2018
Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastomaXuyao Zhang, Shaofei Wang, Yanyang Nan, et al.
Frontiers in Immunology|August 21, 2018
Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin EYichen Wang, Xuyao Zhang, Jiajun Fan, et al.
Cell Death & Disease|April 25, 2024
A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAEYichen Wang, Yanyang Nan, Chunguang Ma, et al.
International Journal of Biological Macromolecules|November 5, 2025
ANGPTL3 nanobody-FGF21 fusion protein ameliorates metabolic dysfunction-associated fatty liver disease via regulation of lipid and glucose metabolism and attenuation of oxidative stressYuanzhen Zhang, Xiaozhi Hu, Zhonglian Cao, et al.
Carcinogenesis|March 15, 2018
Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastomaXuyao Zhang, Wei Chen, Jiajun Fan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 18, 2025
Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8<sup>+</sup> T cell and evading IL-18BP in preclinical modelsYanyang Nan, Min Zhu, Qian Wang, et al.
Pageof 3